Moreover, patients with low/low or low/high co-expression of OCT4/POU5F1P4 appeared to have significantly poorer survival than that of the other groups of ovarian cancer patients (Fig. 8b, right panel). This evidence concerns the gene POU5F1P4 and ovarian cancer.